262 related articles for article (PubMed ID: 26137904)
21. Assessment of PI-RADS v2 for the Detection of Prostate Cancer.
Kasel-Seibert M; Lehmann T; Aschenbach R; Guettler FV; Abubrig M; Grimm MO; Teichgraeber U; Franiel T
Eur J Radiol; 2016 Apr; 85(4):726-31. PubMed ID: 26971415
[TBL] [Abstract][Full Text] [Related]
22. Multiparametric MRI of the prostate: diagnostic performance and interreader agreement of two scoring systems.
Lin WC; Muglia VF; Silva GE; Chodraui Filho S; Reis RB; Westphalen AC
Br J Radiol; 2016 Jun; 89(1062):20151056. PubMed ID: 27007818
[TBL] [Abstract][Full Text] [Related]
23. Inter-reader agreement of the ESUR score for prostate MRI using in-bore MRI-guided biopsies as the reference standard.
Schimmöller L; Quentin M; Arsov C; Lanzman RS; Hiester A; Rabenalt R; Antoch G; Albers P; Blondin D
Eur Radiol; 2013 Nov; 23(11):3185-90. PubMed ID: 23756958
[TBL] [Abstract][Full Text] [Related]
24. Comparison of PI-RADS 2, ADC histogram-derived parameters, and their combination for the diagnosis of peripheral zone prostate cancer.
Lin WC; Westphalen AC; Silva GE; Chodraui Filho S; Reis RB; Muglia VF
Abdom Radiol (NY); 2016 Nov; 41(11):2209-2217. PubMed ID: 27364781
[TBL] [Abstract][Full Text] [Related]
25. Prostate Cancer Detection with Multiparametric Magnetic Resonance Imaging: Prostate Imaging Reporting and Data System Version 1 versus Version 2.
Feng ZY; Wang L; Min XD; Wang SG; Wang GP; Cai J
Chin Med J (Engl); 2016 Oct; 129(20):2451-2459. PubMed ID: 27748338
[TBL] [Abstract][Full Text] [Related]
26. Multiparametric Magnetic-Resonance to Confirm Eligibility to an Active Surveillance Program for Low-Risk Prostate Cancer: Intermediate Time Results of a Third Referral High Volume Centre Active Surveillance Protocol.
Luzzago S; Musi G; Catellani M; Russo A; Di Trapani E; Mistretta FA; Bianchi R; Cozzi G; Conti A; Pricolo P; Ferro M; Matei DV; Mirone V; Petralia G; de Cobelli O
Urol Int; 2018; 101(1):56-64. PubMed ID: 29734177
[TBL] [Abstract][Full Text] [Related]
27. Quality assessment of prostate MRI by PI-QUAL score: Inter-reader agreement and impact on prostate cancer local staging at 3 Tesla.
Coelho FMA; Amaral LTW; Mitsutake LKN; Mussi TC; Baroni RH
Eur J Radiol; 2023 Aug; 165():110921. PubMed ID: 37336037
[TBL] [Abstract][Full Text] [Related]
28. Head-to-head comparison of PI-RADS v2 and PI-RADS v1.
Polanec S; Helbich TH; Bickel H; Pinker-Domenig K; Georg D; Shariat SF; Aulitzky W; Susani M; Baltzer PA
Eur J Radiol; 2016 Jun; 85(6):1125-31. PubMed ID: 27161062
[TBL] [Abstract][Full Text] [Related]
29. [Preliminary applicability evaluation of Prostate Imaging Reporting and Data System version 2 diagnostic score in 3.0T multi-parameters magnetic resonance imaging combined with prostate specific antigen density for prostate cancer].
Zuo MZ; Zhao WL; Wei CG; Zhang CY; Wen R; Gu YF; Li MJ; Zhang YY; Wu JF; Li X; Shen JK
Zhonghua Yi Xue Za Zhi; 2017 Dec; 97(47):3693-3698. PubMed ID: 29325321
[No Abstract] [Full Text] [Related]
30. mEPE-score: a comprehensive grading system for predicting pathologic extraprostatic extension of prostate cancer at multiparametric magnetic resonance imaging.
Gatti M; Faletti R; Gentile F; Soncin E; Calleris G; Fornari A; Oderda M; Serafini A; Strazzarino GA; Vissio E; Bergamasco L; Cirillo S; Papotti MG; Gontero P; Fonio P
Eur Radiol; 2022 Jul; 32(7):4942-4953. PubMed ID: 35290508
[TBL] [Abstract][Full Text] [Related]
31. Which one is better for predicting extraprostatic extension on multiparametric MRI: ESUR score, Likert scale, tumor contact length, or EPE grade?
Asfuroğlu U; Asfuroğlu BB; Özer H; Gönül İI; Tokgöz N; İnan MA; Uçar M
Eur J Radiol; 2022 Apr; 149():110228. PubMed ID: 35255320
[TBL] [Abstract][Full Text] [Related]
32. Histology core-specific evaluation of the European Society of Urogenital Radiology (ESUR) standardised scoring system of multiparametric magnetic resonance imaging (mpMRI) of the prostate.
Kuru TH; Roethke MC; Rieker P; Roth W; Fenchel M; Hohenfellner M; Schlemmer HP; Hadaschik BA
BJU Int; 2013 Dec; 112(8):1080-7. PubMed ID: 23937255
[TBL] [Abstract][Full Text] [Related]
33. Diagnostic accuracy of biparametric vs multiparametric MRI in clinically significant prostate cancer: Comparison between readers with different experience.
Di Campli E; Delli Pizzi A; Seccia B; Cianci R; d'Annibale M; Colasante A; Cinalli S; Castellan P; Navarra R; Iantorno R; Gabrielli D; Buffone A; Caulo M; Basilico R
Eur J Radiol; 2018 Apr; 101():17-23. PubMed ID: 29571792
[TBL] [Abstract][Full Text] [Related]
34. Contemporary Epstein Criteria with Biopsy-Naïve Multiparametric Magnetic Resonance Imaging to Prevent Incorrect Assignment to Active Surveillance in the PI-RADS Version 2.0 Era.
Fan Y; Zhai L; Meng Y; Chen Y; Sun S; Wang H; Hu S; Shen Q; Liu Y; Li D; Feng X; He Q; Wang X; Yu W; Jin J
Ann Surg Oncol; 2018 Nov; 25(12):3510-3517. PubMed ID: 30225837
[TBL] [Abstract][Full Text] [Related]
35. Prostate cancer localization using multiparametric MR imaging: comparison of Prostate Imaging Reporting and Data System (PI-RADS) and Likert scales.
Rosenkrantz AB; Kim S; Lim RP; Hindman N; Deng FM; Babb JS; Taneja SS
Radiology; 2013 Nov; 269(2):482-92. PubMed ID: 23788719
[TBL] [Abstract][Full Text] [Related]
36. Targeted MRI/TRUS fusion-guided biopsy in men with previous prostate biopsies using a novel registration software and multiparametric MRI PI-RADS scores: first results.
Tewes S; Hueper K; Hartung D; Imkamp F; Herrmann TR; Weidemann J; Renckly S; Kuczyk MA; Wacker F; Peters I
World J Urol; 2015 Nov; 33(11):1707-14. PubMed ID: 25774003
[TBL] [Abstract][Full Text] [Related]
37. The Impact of Magnetic Resonance Imaging on Prediction of Extraprostatic Extension and Prostatectomy Outcome in Patients with Low-, Intermediate- and High-Risk Prostate Cancer: Try to Find a Standard.
Radtke JP; Hadaschik BA; Wolf MB; Freitag MT; Schwab C; Alt C; Roth W; Duensing S; Pahernik SA; Roethke MC; Schlemmer HP; Hohenfellner M; Teber D
J Endourol; 2015 Dec; 29(12):1396-405. PubMed ID: 26154571
[TBL] [Abstract][Full Text] [Related]
38. Diagnostic performance of ESUR scoring system for extraprostatic prostate cancer extension: A meta-analysis.
Li W; Dong A; Hong G; Shang W; Shen X
Eur J Radiol; 2021 Oct; 143():109896. PubMed ID: 34416449
[TBL] [Abstract][Full Text] [Related]
39. Multiparametric MRI Apparent Diffusion Coefficient (ADC) Accuracy in Diagnosing Clinically Significant Prostate Cancer.
Pepe P; D'Urso D; Garufi A; Priolo G; Pennisi M; Russo G; Sabini MG; Valastro LM; Galia A; Fraggetta F
In Vivo; 2017; 31(3):415-418. PubMed ID: 28438871
[TBL] [Abstract][Full Text] [Related]
40. Extra-prostatic extension grading system: correlation with MRI features and integration of capsular enhancement sign for "enhanced" detection of T3a lesions.
Martini F; Pigati M; Mattiauda M; Ponzano M; Piol N; Pigozzi S; Spina B; Cittadini G; Giasotto V; Zawaideh JP
Br J Radiol; 2024 May; 97(1157):971-979. PubMed ID: 38544291
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
